The effectiveness of chelation therapy has long been debated. In 2002, the National Center for Complementary and Alternative Medicine announced a study, “ To Assess Chelation Therapy (TACT)” to establish adequate research to verify chelation therapy as a safe and effective alternative therapy. The trial represents an important milestone in assessing the role of chelation therapy. A large scale randomized, double blind study includes patients of 50 or older who have had a heart attack and there are a few other criteria you can reference below.
It’s not too late to participate. This randomized, double-blind study is nearing its end to enroll patients but there is still room for interested patients that would like an opportunity to contribute and possibly benefit. This $30 million study led by Gervasio A. Lamas, MD is director of cardiovascular research and academic affairs at Mount Sinai Medical Center-Miami Heart Institute in Miami Beach, Florida. The Data Coordinating Center and Quality of Life Coordinating Center are located at Duke Clinical Research Institute in Durham, North Carolina. Further, an independent Data Safety Monitoring Board oversees the study. The purpose of this study is to determine if EDTA therapy and/or high dose vitamin therapy is effective for the treatment of coronary artery disease.
For more information, please review the attachments below:
